v3.21.1
Consolidated Statements of Redeemable Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Treasury stock
Senior A
Senior B
Junior
Redeemable
Beginning balance, redeemable preferred stock (in shares) at Jan. 31, 2018           13,674,365 9,197,142 32,746,041 42,560,530
Beginning balance, redeemable preferred stock at Jan. 31, 2018 $ 176,291         $ 57,022 $ 43,962 $ 32,746 $ 42,561
Redeemable preferred stock                  
Accretion of redeemable preferred stock 30,199         $ 22,289 $ 7,910    
Ending balance, redeemable preferred stock (in shares) at Jan. 31, 2019           13,674,365 9,197,142 32,746,041 42,560,530
Ending balance, redeemable preferred stock at Jan. 31, 2019 206,490         $ 79,311 $ 51,872 $ 32,746 $ 42,561
Beginning balance, stockholders' equity (in shares) at Jan. 31, 2018   1,638,331              
Beginning balance, stockholders' equity (deficit) at Jan. 31, 2018 (167,683) $ 16 $ 0 $ (167,700) $ 0        
Stockholders’ equity (deficit)                  
Net loss (15,062)     (15,062)          
Stock-based compensation expense 1,447   1,447            
Exercise of stock options and vesting of restricted stock units (in shares)   316,063              
Exercise of stock options and vesting of restricted stock units 361 $ 3 358            
Issuance of common stock in connection with acquisition (in shares)   40,327              
Issuance of common stock in connection with acquisition 163 $ 1 162            
Issuance of common stock warrants 0                
Accretion of redeemable preferred stock (30,199)   (1,967) (28,232)          
Ending balance, stockholders' equity (in shares) at Jan. 31, 2019   1,994,721              
Ending balance, stockholders' equity (deficit) at Jan. 31, 2019 (210,974) $ 20 0 (210,994)        
Redeemable preferred stock                  
Accretion of redeemable preferred stock 56,175         $ 32,706 $ 23,469    
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock (in shares)           (13,674,365) (9,197,142) (32,746,041) (42,560,530)
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock (262,665)         $ (112,018) $ (75,341) $ (32,746) $ (42,561)
Ending balance, redeemable preferred stock (in shares) at Jan. 31, 2020           0 0 0 0
Ending balance, redeemable preferred stock at Jan. 31, 2020 0         $ 0 $ 0 $ 0 $ 0
Stockholders’ equity (deficit)                  
Net loss (20,293)     (20,293)          
Stock-based compensation expense $ 6,177   6,177            
Exercise of stock options and vesting of restricted stock units (in shares) 691,371 734,382              
Exercise of stock options and vesting of restricted stock units $ 1,809 $ 7 1,802            
Issuance of common stock warrants 833   833            
Accretion of redeemable preferred stock (56,175)   (2,977) (53,198)          
Payment of preferred stock dividends (14,955)   (14,955)            
Issuance of common stock, net of issuance costs (in shares)   7,812,500              
Issuance of common stock, net of issuance costs 124,370 $ 78 124,292            
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock (in shares)   25,311,535              
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock 262,665 $ 253 262,412            
Cashless exercise of common stock warrants (in shares)   168,862              
Cashless exercise of common stock warrants 2 $ 2              
Conversion and exercise of preferred stock warrants into common stock (in shares)   588,763              
Conversion and exercise of preferred stock warrants into common stock 8,805 $ 6 8,799            
Treasury stock from vesting of restricted stock units (399)       (399)        
Ending balance, stockholders' equity (in shares) at Jan. 31, 2020   36,610,763              
Ending balance, stockholders' equity (deficit) at Jan. 31, 2020 101,865 $ 366 386,383 (284,485) (399)        
Ending balance, redeemable preferred stock (in shares) at Jan. 31, 2021           0 0 0 0
Ending balance, redeemable preferred stock at Jan. 31, 2021 0         $ 0 $ 0 $ 0 $ 0
Stockholders’ equity (deficit)                  
Net loss (27,292)     (27,292)          
Stock-based compensation expense $ 13,489   13,489            
Exercise of stock options and vesting of restricted stock units (in shares) 2,216,368 2,459,782              
Exercise of stock options and vesting of restricted stock units $ 5,300 $ 25 5,275            
Issuance of common stock, net of issuance costs (in shares)   5,750,000              
Issuance of common stock, net of issuance costs 174,510 $ 57 174,453            
Cashless exercise of common stock warrants (in shares)   60,338              
Cashless exercise of common stock warrants 0 $ 1 (1)            
Treasury stock from vesting of restricted stock units (4,566)       (4,566)        
Ending balance, stockholders' equity (in shares) at Jan. 31, 2021   44,880,883              
Ending balance, stockholders' equity (deficit) at Jan. 31, 2021 $ 263,306 $ 449 $ 579,599 $ (311,777) $ (4,965)